(Q36889570)

16 August 2017

1 reference

title

Cardiotoxicity of antimalarial drugs (English)

1 reference

16 August 2017

0 references

1

Nicholas J White

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Lancet Infectious Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

549-558

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

16 August 2017

1 reference

7 January 2021

Cardiac effects of antimalarial treatment with halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Antimicrobial-associated QT interval prolongation: pointes of interest

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

On the nature of orthostatic hypotension in acute malaria *

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

The impact of posture on cardiac repolarization: more than heart rate?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Modulation of QT interval during autonomic nervous system blockade in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I(Kr), and the underlying hERG ion channel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Effect of autonomic nervous function on QT interval in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Diurnal variation of the QT interval--influence of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Effects of anxiety on QT dispersion in healthy young men.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Why did QT dispersion die?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Electrocardiographic monitoring in severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Prolongation of the QTc interval in African children treated for falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

There is little sense in "common" QT correction methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

QT analysis: a complex answer to a 'simple' problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Variability of heart rate correction methods for the QT interval

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

QT correction methods in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

QTc interval (cardiac repolarization): lengthening after meals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

QT prolongation with antimicrobial agents: understanding the significance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

alpha-Adrenergic blocking properties of quinine HCl

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Effects of quinidine and verapamil on human cardiovascular alpha1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinine by continuous intravenous drip in the treatment of acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinidine-induced open channel block of K+ current in rat ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinine inhibits mitochondrial ATP-regulated potassium channel from bovine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

The antimalarial agent mefloquine inhibits ATP-sensitive K-channels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Modulation of HERG potassium channels by extracellular magnesium and quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Voltage-Dependent Profile of HumanEther-a-go-go-Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinine and quinidine: a comparison of EKG effects during the treatment of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Antiarrhythmic Activity of Quinine in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Effects of quinine and quinidine on the transient outward and on the L-type Ca(2+) current in rat ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A trial of artemether or quinine in children with cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Quinine pharmacokinetics in young children with severe malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Massive chloroquine intoxication: importance of early treatment and pre-hospital treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Treatment of acute chloroquine poisoning: a 5-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Diazepam does not improve the mechanical performance of rat cardiac papillary muscle exposed to chloroquine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Treatment of severe chloroquine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Cardiovascular toxicity and distribution kinetics of intravenous chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Parenteral chloroquine for treating falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Chloroquine-induced venodilation in human hand veins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Cardiopulmonary effects of antimalarial drugs. 1. 4-Aminoquinolines: chloroquine quinetholate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Depressant effects of chloroquine on the isolated guinea-pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Chloroquine blocks the background potassium current in guinea pig atrial myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Properties of mouse connexin 30.2 and human connexin 31.9 hemichannels: implications for atrioventricular conduction in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Comparative cardiac effects of halofantrine and chloroquine plus chlorpheniramine in children with acute uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Inhibition of HERG potassium channels by the antimalarial agent halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Antimalarial drugs: QT prolongation and cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Inhibition of cardiac Na+ current by primaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Cardiopulmonary effects of antimalarial drugs. VI. Adenosine, quinacrine and primaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Cardiopulmonary effects of antimalarial drugs. 3. Diaminopyrimidines: trimethoprim (WR 5949) and 5-piperonyl-2,4-diaminopyrimidine (WR 40,070).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Fatal neurotoxicity of arteether and artemether

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Neurotoxicity in animals due to arteether and artemether

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Studies of the neurotoxicity of oral artemisinin derivatives in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Grapefruit juice increases the bioavailability of artemether

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970187-1

7 January 2021

10.1016/S1473-3099(07)70187-1

Identifiers

DOI

1 reference

16 August 2017

1 reference